Down Regulation of Stem Cell Colony Formation by Purified CD8 Lymphocytes and CD8 Conditioned Medium: Potential Importance for Bone Marrow Transplantation in Leukemia

References

• Storb R., Deeg H., Whitehead J., et al. Methotonexate and cyclosporine vs. cyclosporine alone for prevention of GvHd after bone marrow transplantation for leukemia. N, Eng. J. Med. 1986; 314: 729–35
   PubMed Web of Science ®Google Scholar
• Byers V., Blazar B., Antin S., Henslee J., et al. Anti pan-T MoAb-Ricin A chain in initial therapy in acute GvHd. Expt. Hemat. 1988; 16: 518–28
   Web of Science ®Google Scholar
• Saral R., Bums W., Laskin O. V., et al. A cyclonic prophylaxis of herpes simplex virus infection: A randomized study in bone marrow transplant recipients. JV. Eng. J. Med. 1981; 305: 63–7
   PubMed Web of Science ®Google Scholar
• Wagner J. E., Donnenberg A. D., Noga S. J., et al. Lymphocyte depletion of donor bone marrow by CCE: Results of Phase I clinical trial. Blood 1988; 72: 1168–76
   PubMed Web of Science ®Google Scholar
• Reisner Y., Kapoor N., Kirkpatrick D. Transplantation for ALL with HLA-A and HLA-B non-identical parental marrow cells fractionated with SBA and sheep RBC. Lancet 1981; 2: 327–30
   PubMed Web of Science ®Google Scholar
• Filipovic A., Vallera D., Youle R. Ex vivo treatment of donor BM with anti T-cell immunotoxins for prevention of GvHd. Lancet 1984; 1: 469–71
   PubMed Web of Science ®Google Scholar
• Herve P., Flesch M., Cahn J., et al. Removal of bone marrow T-cells with OKT3-OKT11 MoAbs to prevent acute GvHd-A pilot study with 10 patients. Transplantation 1985; 39: 138–43
   PubMed Web of Science ®Google Scholar
• Marmont A. M., Gale R. P., Butturini A., Goldman J. M., Martelli M. F., Prentice H. G., Slavin Storb S. R., Truitt R. L., Van Bekkum D. W. T-cell depletion in allogenic bone marrow transplantation: Progress and problems. Hematolgica 1989; 74: 235–48
   PubMedGoogle Scholar
• Mitsuyasu R., Champlin R., Gale R., et al. Treatment of donor bone marrow with monoclonal anti T-cell antibody and complement for the prevention of GvHd. Ann. Int. Med. 1986; 105: 20–6
   PubMed Web of Science ®Google Scholar
• Antin J. H., Bierer B. E., Smith B. R., . Depletion of bone marrow T-lymphocytes with an anti CD-5 MoAb-Immunotoxin: Effective prophylaxis of GvHd. Bone Marrow Processing and Purging, S. Gross, A. Gee, D. Worthington-White, et al, Wiley-Liss, NY 1990; 207–15
   Google Scholar
• Egeland T., Albrechtsen D., Martin P. J., Hansen J. A. Immunomagnetic depletion of CD6+ cells from bone marrow and peripheral blood. Bone Marrow Transplantation 1990; 5: 193–8
   PubMed Web of Science ®Google Scholar
• Kozak R. W., Fitzgerald D. P., Atcher R. W., Goldman C. K., Nelson D. L., Gansow O. A., Pastan I., Waldman T. A. Selective elimination of alloresponsive T-cells to human transplantation antigens by toxin conjugated anti IL-2 receptor antibodies. J. Immunol 1990; 144: 3417–23
   PubMed Web of Science ®Google Scholar
• Champlin R., Gajewski J., Feig S., et al. Selective removal of T8 positive T-lymphocytes for prevention of GvHd following allogeneic BMT. Transplantation Proceeding 1989; 21: 2947–8
   PubMed Web of Science ®Google Scholar
• Champlin R., Ho W., Gajeswki J., Feig S., Burnison M., Holley G., Greenberg P., Lee K., Schmid I., et al. Selective depletion of CD8+ T-cells for prevention of GvHd after allogenic bone marrow transplantation. Blood 1990; 76: 418–23
   PubMed Web of Science ®Google Scholar
• Gazitt Y., He Y.-J., Rios A., Gross S. Immunomagnetic purging of T8 cells from peripheral blood and bone marrow: A preclinical study. Leukemia and Lymphoma 1992, (in press)
   PubMed Web of Science ®Google Scholar
• Boyum A. Isolation of mononuclear cells and granulocytes from human blood. J. Clin. Lab. Invest. 1968; 21: 31–4
   Web of Science ®Google Scholar
• Gee A. P., Lee C., Bruce K., Jansen W., Graham-Pole J., Pawlina T., Pick T., Harvey W., Koch P., Gross S. Immunomagnetic purging and allogeneic transplantation of stage D neuroblastoma. Bone Marrow Transplantation 1987; 2: 89–98
   Web of Science ®Google Scholar
• Weinstein R., Biordan M. A., Wenc K., Dreczko S., Zhou M., Dainiak N. Dual role of fibronectin in hematopoietic differentiation. Blood 1989; 73: 111–16
   PubMed Web of Science ®Google Scholar
• O'Murchava E. T., Horland A., Neimas R. S., Valeri R. C. Morphology of cells grown in CFU-GEMM tissue culture assay from mononuclear cells obtain from peripheral blood and bone marrow of normal volunteers. Expt. Hematology 1988; 16: 235–39
   PubMed Web of Science ®Google Scholar
• Bagby G. C. T-lymphocytes involved in inhibition of granulopoiesis in two neutropenic patients are of the cytotoxic suppressor (T3-T8) subset. J. Clin. Invest. 1981; 68: 1597–1600
   PubMed Web of Science ®Google Scholar
• Grillot-Courvalin C., Vinci G., Tsapis A., Dokhdar M. C., Vainchenker W., Brouet J.-C. A syndrome of T., hypherlymphocytosis: variations in phenotype and cytotoxic activities of granular cells and evaluation of their role in neutropenia. Blood 1986; 69: 1204–10
   Google Scholar
• Torok-Storb B., Hansen J. A. Modulation in vitro of BFU-E growth by normal la positive T-cells in restricted by HLA-DR. Nature 1982; 298: 473–74
   PubMed Web of Science ®Google Scholar
• Vinci G., Vernant J.-P., Cordonnier C., Henri A., Breton-Gorius J., Bochant H., Vainchenker W. In vitro inhibition of hematopoiesis by HNKI, DR-positive T-cells and monocytes after allogeneic bone marrow transplantation. Expt. Hematoi 1987; 15: 54–64
   PubMed Web of Science ®Google Scholar
• Savary C. A., Lotzova E. IL-2 and killer cells in cancer, E. Lotzova, R. Herberman. CRC Press, FL 1990; 89–91
   Google Scholar
• Favrot M., Philip T., Combaret V., Lemerle J., Marie J.-P., Bernard A. Effect of in vitro therapy with CD8 monoclonal antibodies on delayed engraftment after autologous bone marrow transplantation. Bone Marrow Transplantation 1990; 5: 33–38
   PubMed Web of Science ®Google Scholar